Thermo Fisher Scientific, Inc. (TMO) Financials
Key financial figures for Thermo Fisher Scientific, Inc. (Q2 2026).
Thermo Fisher grew Q2 2026 revenue 10% to $11.99 billion with 5% organic growth, GAAP diluted EPS up 9% to $4.68 and adjusted EPS up 13% to $6.03. Revenue grew 10% year over year to $11.99 billion (vs. $10.85 billion in Q2 2025), including 5% organic revenue growth. GAAP diluted EPS rose 9% to $4.68; adjusted (non-GAAP) diluted EPS rose 13% to $6.03. GAAP operating margin expanded to 17.4% from 16.9%; adjusted operating margin expanded to 22.8% from 21.9%, with adjusted operating income up 15% to $2.73 billion. Figures are for Q2 2026, as Thermo Fisher Scientific Inc. reported them.
- Revenue
- $12.0B
- Net Income
- $1.7B
- EPS
- $4.68
- Total Assets
- $113.2B
- Operating Cash Flow
- $2.1B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $12.0B | $1.7B | $4.68 | 17.4% | $1.7B |
| Q1 FY2026 | $11.0B | $1.7B | $4.43 | 16.93% | $816M |
| Q4 FY2025 | $12.2B | $2.0B | $5.21 | 18.85% | $3.0B |
| Q3 FY2025 | $11.1B | $1.6B | $4.27 | 18.66% | $1.8B |
| Q2 FY2025 | $10.9B | $1.6B | $4.28 | 17.66% | $1.1B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $44.6B | $6.7B | $17.74 | 18.2% | $6.3B |
| FY2024 | $42.9B | $6.3B | $16.53 | 17.87% | $7.3B |
| FY2023 | $42.9B | $6.0B | $15.45 | 17.37% | $6.9B |
Frequently asked questions
What was Thermo Fisher Scientific Inc.'s revenue last quarter?
Thermo Fisher Scientific Inc. reported revenue of $11.99 billion for Q2 FY2026, up 10.5% from the same period a year earlier.
Is Thermo Fisher Scientific Inc. profitable?
Yes. Thermo Fisher Scientific Inc. reported net income of $1.74 billion for Q2 FY2026, a net margin of 14.47% on revenue.
How has Thermo Fisher Scientific Inc.'s margin trended?
Operating margin was 17.4% in Q2 FY2026, compared with 17.66% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Thermo Fisher Scientific Inc. generate?
Thermo Fisher Scientific Inc. generated free cash flow of $1.68 billion in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Thermo Fisher Scientific, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.